- Home
- ARKO vs IMTX Comparison
ARKO vs IMTX Comparison
Compare ARKO & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARKO
- IMTX
- Stock Information
- Founded
- ARKO 1970
- IMTX N/A
- Country
- ARKO United States
- IMTX Germany
- Employees
- ARKO N/A
- IMTX N/A
- Industry
- ARKO Oil Refining/Marketing
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ARKO Energy
- IMTX Health Care
- Exchange
- ARKO Nasdaq
- IMTX Nasdaq
- Market Cap
- ARKO 566.0M
- IMTX 653.9M
- IPO Year
- ARKO N/A
- IMTX N/A
- Fundamental
- Price
- ARKO $4.96
- IMTX $6.26
- Analyst Decision
- ARKO Buy
- IMTX Strong Buy
- Analyst Count
- ARKO 3
- IMTX 4
- Target Price
- ARKO $7.50
- IMTX $14.67
- AVG Volume (30 Days)
- ARKO 517.7K
- IMTX 973.4K
- Earning Date
- ARKO 08-06-2025
- IMTX 08-13-2025
- Dividend Yield
- ARKO 2.45%
- IMTX N/A
- EPS Growth
- ARKO N/A
- IMTX N/A
- EPS
- ARKO 0.08
- IMTX N/A
- Revenue
- ARKO $8,131,937,000.00
- IMTX $152,823,253.00
- Revenue This Year
- ARKO N/A
- IMTX N/A
- Revenue Next Year
- ARKO N/A
- IMTX N/A
- P/E Ratio
- ARKO $62.39
- IMTX N/A
- Revenue Growth
- ARKO N/A
- IMTX 83.61
- 52 Week Low
- ARKO $3.51
- IMTX $3.30
- 52 Week High
- ARKO $7.84
- IMTX $13.09
- Technical
- Relative Strength Index (RSI)
- ARKO 54.45
- IMTX 58.89
- Support Level
- ARKO $4.79
- IMTX $5.29
- Resistance Level
- ARKO $5.09
- IMTX $5.56
- Average True Range (ATR)
- ARKO 0.20
- IMTX 0.35
- MACD
- ARKO -0.03
- IMTX 0.04
- Stochastic Oscillator
- ARKO 49.08
- IMTX 85.03
About ARKO ARKO Corp.
ARKO Corp owns and operates convenience stores in the United States. Some of its regional store brands include Stop, Admiral, Apple Market, BreadBox, E-Z Mart, fas mart, Li'l Cricket, and Next Door Store. Its retail store offers hot food service, beverages, cigarettes & other tobacco products, candy, salty snacks, grocery, beer, and general merchandise. ARKO operates in four segments: Retail segment, Wholesale segment, fleet fueling segment, and GPM Petroleum segment. The company derives the majority of its revenue from retail and wholesale distribution of fuel.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.